Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Interpretation of somatic POLE mutations in endometrial carcinomaThe Journal of pathology, 2020-03, Vol.250 (3), p.323 [Peer Reviewed Journal]ISSN: 1096-9896 ;EISSN: 1096-9896 ;DOI: 10.1002/path.5372Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomasThe Journal of pathology, 2020-03, Vol.250 (3), p.312 [Peer Reviewed Journal]ISSN: 1096-9896 ;EISSN: 1096-9896 ;DOI: 10.1002/path.5373Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Abstract P1-01-16: Detection of disseminated tumor cells in DCIS patients impacts local recurrenceCancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-01-16 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-P1-01-16Full text available |
|
4 |
Material Type: Article
|
EP416 Large conization: an effective surgical approach for fertility preservation in young women with early stage cervical cancerInternational journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A272-A272 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-ESGO.475Full text available |
|
5 |
Material Type: Article
|
EP1003 Meigs’ syndrome with elevated serum CA125: case report and review of the literatureInternational journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A529-A530 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2019-ESGO.1047Full text available |
|
6 |
Material Type: Article
|
576 Ovarian carcinoma precursor lesions in a walk-in series of opportunistic and prophylactic salpingectomies at the Tuebingen women’s hospitalInternational journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A252-A252 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.431Full text available |
|
7 |
Material Type: Article
|
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017Annals of oncology, 2018-10, Vol.29 (10), p.2153-2153 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;ISSN: 1569-8041 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx806 ;PMID: 29733336Full text available |
|
8 |
Material Type: Article
|
144 Ovarian carcinoma long-term survivors: a large single center study at the tübingen university women’s hospitalInternational journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A63-A63 [Peer Reviewed Journal]2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.124Full text available |
|
9 |
Material Type: Article
|
267 Histopathologic ultrastaging of sentinel lymph nodes in endometrial carcinoma: A retrospective analysis of the tuebingen women’s hospital 2006-2016 patient cohortInternational journal of gynecological cancer, 2020-11, Vol.30 (Suppl 3), p.A109-A110 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2020-IGCS.229Full text available |
|
10 |
Material Type: Article
|
113 Improved preoperative risk stratification in endometrial cancer: External validation of the ENDORISK network model in a population-based case seriesInternational journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A77-A77 [Peer Reviewed Journal]IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-ESGO.118Full text available |
|
11 |
Material Type: Article
|
Abstract P3-01-14: A nomogram to predict the likelihood of axillary non-sentinel lymph node metastases in sentinel lymph node positive primary breast cancer patientsCancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-01-14 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS15-P3-01-14Full text available |
|
12 |
Material Type: Article
|
Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT1-11-02-OT1-11-02 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS18-OT1-11-02Full text available |
|
13 |
Material Type: Article
|
Abstract P6-17-22: Progression free survival (PFS) and overall survival (OS) of patients treated with trastuzumab emtansine (T-DM1) after previous treatment with pertuzumab in patients with advanced breast cancer (NCT02338167)Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-17-22 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS18-P6-17-22Full text available |
|
14 |
Material Type: Article
|
Abstract P6-17-37: Therapy landscape of patients with metastatic, HER2 positive breast cancer - Data from the real world breast cancer registry PRAEGNANT (NCT02338167)Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-17-37 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS18-P6-17-37Full text available |
|
15 |
Material Type: Article
|
Abstract P3-11-05: Reliability and acceptance of e-based survey instruments for measuring patient reported outcomes (PRO) in breast cancer patients: First results of the ePROCOM studyCancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-11-05 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS16-P3-11-05Full text available |
|
16 |
Material Type: Article
|
LEFTY2 inhibits endometrial receptivity by downregulating Orai1 expression and store-operated Ca²+ entryThe Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. ;ISSN: 0946-2716 ;EISSN: 1432-1440Full text available |
|
17 |
Material Type: Article
|
Abstract GS1-06: Extended adjuvant bisphosphonate treatment over five years in early breast cancer does not improve disease-free and overall survival compared to two years of treatment: Phase III data from the SUCCESS A studyCancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS1-06-GS1-06 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-GS1-06Full text available |
|
18 |
Material Type: Article
|
Abstract P6-11-10: Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registryCancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P6-P6-11-10 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-P6-11-10Full text available |
|
19 |
Material Type: Article
|
Abstract GS5-07: International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer: Results from the PADDY studyCancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS5-07-GS5-07 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS18-GS5-07Full text available |
|
20 |
Material Type: Article
|
Abstract PD1-02: Cancer predisposition genes in metastatic breast cancer – Association with metastatic pattern, prognosis, patient and tumor characteristicsCancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD1-02-PD1-02 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.SABCS17-PD1-02Full text available |